Praetorian Acquisition Corp. (PTOR) is a special purpose acquisition company (SPAC) that seeks to identify and merge with innovative firms in high-growth sectors, with a particular focus on technology and healthcare. Leveraging a seasoned management team with deep industry expertise, PTOR aims to deliver substantial value to shareholders through strategic mergers and partnerships. As a publicly traded entity, the company presents institutional investors with a unique opportunity to access transformative market opportunities, capitalizing on the increasing trend towards SPAC investments to foster long-term growth and profitability.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.66 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $25.49M |
| Float | $25.49M |
| % Insiders | 0.00% |
| % Institutions | 65.74% |